Funtleyder Leslie D.
- SEC CIK
- 0001775394
No open-market purchases or sales filed in the past year.
Current role at each company
- APLT Applied Therapeutics, Inc.Chief Financial Officeras of Feb 3, 2026
- RVPH Reviva Pharmaceuticals Holdings, Inc.Directoras of Dec 19, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Funtleyder Leslie D. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
APLT Applied Therapeutics, Inc.
Chief Financial Officer5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2025 (view filing)8:30 PM ET | Mar 4 | 2 days | Funtleyder Leslie D.See Remarks | SSale | −14.5K | $0.44 | −$6.38K | −3.6%390.5K after | |
| Feb 7, 2025 (view filing) | Feb 6 | 1 day | Funtleyder Leslie D.See Remarks | SSale | −22.9K | $0.61 | −$14.0K | −5.4%405.0K after | |
| Aug 23, 2024 (view filing) | Aug 22 | 1 day | Funtleyder Leslie D.Chief Financial Officer | SSale | −13.5K | $5.83 | −$78.9K | −4.6%277.9K after | |
| Jun 10, 2024 (view filing) | Jun 6 | 4 days | Funtleyder Leslie D.Chief Financial Officer | SSale | −17.0K | $4.32 | −$73.4K | −5.5%291.4K after | |
| Mar 18, 2024 (view filing) | Mar 14 | 4 days | Funtleyder Leslie D.Chief Financial Officer | SSale | −28.7K | $5.39 | −$154.8K | −8.5%308.4K after |